top of page
Browse by category
Search


NICE approves endoscopic sleeve gastroplasty for weight loss management
The UK’s National Institute for Health and Care Excellence (NICE) has approved the use of endoscopic sleeve gastroplasty (ESG) for weight...


Intraoperative leak tests correlated with increase in staple line leakage but a lower rate of postoperative bleeding
Intraoperative leak test (IOLT) is correlated with an increase in staple line leakage (SLL) when included as a part of a sleeve...


First procedures utilising ReShape’s next-generation Lap-Band 2.0 FLEX
ReShape Lifesciences has announced that the first procedures utilising the company’s next generation, enhanced Lap-Band 2.0 FLEX, have...


Journal Watch 22/2/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


Interdisciplinary therapy programme reduces inflammation and cardiometabolic risk in adolescents with obesity
After a one-year interdisciplinary therapy programme that included clinical, nutritional, psychological and exercise counselling, a group...


Tranexamic acid results in better LSG outcomes compared to placebo
Tranexamic acid (TXA) demonstrates a robust safety and efficacy profile for its use in patients undergoing laparoscopic sleeve...


Obesity Medicine Association, Obesity Action Coalition and Found launch of Obesity Medicine Scholarship
Found, one of the largest medically-assisted weight loss programmes in the US, is partnering with the Obesity Medicine Association (OMA)...


Enrolment complete in Vogenx’ Phase 2 Trial of mizagliflozin for post-bariatric hypoglycaemia
Vogenx has completed patient enrolment of a mid-Phase 2 clinical dose ranging study (VGX-001-012) evaluating mizagliflozin in patients...


LSG: The balance between superior weight loss and preventing the onset of reflux
A smaller bougie size, shorter distance from the staple line to pylorus and to the angle of His were independently related to increased...


No overall cost–benefit after RYGB versus SG among T2DM patients
Patients with type 2 diabetes (T2DM) at baseline undergoing RYGB appear to experience a reduced need for ambulatory T2DM monitoring and...
Browse by tag






bottom of page